TrialClinical cancer research : an official journal of the American Association for Cancer Research2021

Single-Agent Ibrutinib for Rituximab-Refractory Waldenström Macroglobulinemia: Final Analysis of the Substudy of the Phase III Innovate

Judith Trotman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.